# AIxplorerBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aixplorerbio

- Industry: Pharmaceuticals
- Headquarters: Jiaxing, China
- Total disclosed funding: $7.7M
- Latest round: Angel (Apr 26, 2021)
- Investors on record: 2

## About

Founded in 2021 and based in Jiaxing, China, AIxplorerBio was established as a drug discovery company integrating artificial intelligence into pharmaceutical development. The company concentrates on therapeutic areas such as autoimmune conditions and neurodegenerative diseases, building a platform to accelerate early-stage drug development. In April 2021, the company closed a round of venture funding. The company develops AI-based solutions for new drug discovery, particularly in the fields of immunology and neurology. The company generates revenue through the licensing of AI-driven drug discovery technologies and commercialization of proprietary drug products. The company intends to enhance its AI drug discovery platform and expand therapeutic pipelines targeting complex chronic diseases, while exploring strategic collaborations to accelerate clinical validation.

## Funding rounds

- Angel, Apr 26, 2021, $7.7M — Viva Ventures Biotech, Baitu Shengke

## Investors

- Viva Ventures Biotech (https://capitalatlas.ai/funds/viva-ventures-biotech) — Angel
- Baitu Shengke — Angel